18 results found.

Head and Neck Neoplasms Clinical Trial using methotrexate; afatinib

Boehringer Ingelheim - Recruiting 18 years or older.
- A Randomised, Open-label, Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) Versus Intravenous Methotrexate in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Who Have Progressed After Platinum-based Therapy.
methotrexate; afatinib

Head and Neck Neoplasms Clinical Trial using Placebo; Afatinib

Boehringer Ingelheim - Recruiting 18 years or older.
- A Randomised, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Afatinib (BIBW 2992) as Adjuvant Therapy After Chemo-radiotherapy in Primary Unresected Patients With Stage III, IVa, or IVb Loco-regionally Advanced Head and Neck Squamous Cell Carcinoma.
Placebo; Afatinib

Head and Neck Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 21 years or older.
- Pilot Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan.

Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasm Clinical Trial using 5-Fluoro-2-Deoxycytidine (FdCyd); Tetrahydrouridine (THU)

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU).
5-Fluoro-2-Deoxycytidine (FdCyd); Tetrahydrouridine (THU)

Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasm Clinical Trial using Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine.
Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms, or Clinical Trial using Tumor biopsy; Phlebotomy

Stanford University - Recruiting 18 years or older.
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers.
Tumor biopsy; Phlebotomy

Carcinoma, Squamous Cell, Head and Neck Neoplasms, or Oropharynge Clinical Trial using Assessment of Oral HPV Infection

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- Monitoring of Oral HPV Infection in HPV-positive Oropharyngeal Squamous Cell Carcinoma During and After Chemoradiotherapy (CRT).
Assessment of Oral HPV Infection

Mouth Neoplasms, Head and Neck Neoplasms, Tongue Neoplasms, or Ca Clinical Trial using Rapamycin; Biopsy; Dynamic CT Perfusion; Positron Emission Tomography; Measurement Serum Cytokines

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 80 years.
- A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer.
Rapamycin; Biopsy; Dynamic CT Perfusion; Positron Emission Tomography; Measurement Serum Cytokines

Head and Neck Neoplasms Clinical Trial using Ketogenic diet

University of Iowa - Recruiting 18 years or older.
- A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Head and Neck Cancer.
Ketogenic diet

Malignant Neoplasm of Breast, CNS Malignancy, Malignant Neoplasm Clinical Trial using Alisertib; Pazopanib

University of Illinois at Chicago - Recruiting 18 years or older.
- Phase I Study of Aurora A Kinase Inhibitor (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy in Solid Tumors.
Alisertib; Pazopanib

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrent Disease, Clinical Trial using BKM120

Centre Leon Berard - Recruiting 18 years or older.
- A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a PI3K Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy.
BKM120

Head and Neck Neoplasms Clinical Trial

Technische Universit„t Dresden - Recruiting 18 years to 70 years.
- Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO.

Head and Neck Neoplasms Clinical Trial

Montefiore Medical Center - Recruiting N/A or older.
- Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy.

Carcinoma, Non-Small-Cell Lung, or Head and Neck Neoplasms Clinical Trial using [18F]-ML-10 in conjunction with PET imaging

Aposense Ltd. - Recruiting 18 years or older.
- A Prospective, Multicenter Study, to Evaluate the Efficacy and Safety of [18F]-ML-10, a Positron Emission Tomography (PET) Imaging Radiotracer, in Early Detection of Response of Non-Hematological Tumors to Concurrent Chemoradiotherapy.
[18F]-ML-10 in conjunction with PET imaging

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, or Clinical Trial using cetuximab (associated with radiotherapy); cisplatin (associated to radiotherapy)

Azienda USL 4 Prato - Recruiting 18 years or older.
- Multiinstitutional Open Label Randomized Phase II Study Comparing Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy as Firstline Treatment for Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-NHSCC).
cetuximab (associated with radiotherapy); cisplatin (associated to radiotherapy)

Head and Neck Neoplasms, Head and Neck Cancer, Wounds, or Ulcer Clinical Trial using silver-releasing dressings

National Taiwan University Hospital - Recruiting 18 years or older.
- The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound.
silver-releasing dressings

Head and Neck Neoplasms Clinical Trial using BAY 43-9006

Jules Bordet Institute - Recruiting 18 years or older.
- .
BAY 43-9006

Head and Neck Neoplasms Clinical Trial using Transamin

Taichung Veterans General Hospital - Recruiting 20 years to 80 years.
- If Tranexamic Acid Could Reduce the Duration of Drainage Tube Placement ? -A Prospective Randomized Study in Head and Neck Surgery Patients.
Transamin